Stock vs Stock Comparison

Embecta Corp. vs Agilent Technologies, Inc.

A wins the Tale of the Tape 6–3.

EMBC
A$137.40

🏆 Tale of the Tape

36
EMBCA
8.8%Profitability (Net Margin)18.8%
Valuation (P/E)27.3x
23.2%Efficiency (ROIC)11.8%
6/9Health (Piotroski F)5/9
Safety (Altman Z)4.6
-3.8%Growth (Rev YoY)6.7%
Risk (Sharpe 1Y)0.32
-2.68xBalance Sheet (D/E)0.89x
FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Fundamentals

MetricEMBCA
Market Cap$38.2B
P/E Ratio27.3x
Forward P/E20.5x
P/B5.37x
Dividend Yield0.75%
Beta1.22

Quantitative Metrics

MetricEMBCA
DCF Fair Value$90.31$50.34
DCF Upside-57.1%
Piotroski F6/95/9
Altman Z4.57
Beneish M-3.26-2.46
FCF Yield3.41%
Net Debt/EBITDA4.1x0.7x
ROIC23.2%11.8%
WACC12.1%
ROIC – WACC-0.3pp
Gross Margin62.6%52.4%
Net Margin8.8%18.8%
Rev Growth YoY-3.8%6.7%
Sharpe (1Y)0.32
Max Drawdown 3Y
FCF Payout Ratio19%24%

EMBC Price

Loading chart...

A Price

Loading chart...

ETF Exposure

EMBC found in:

XHE0.48%
VFVA0.09%
SLYV0.02%
SPSM0.01%
VHT0.01%
SPTM0.00%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

EMBC vs A: Head-to-Head Analysis

Embecta Corp. (EMBC) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, EMBC generates a return on invested capital (ROIC) of 23.2% compared to A's 11.8%. This suggests EMBC is more effective at deploying capital to generate shareholder returns.

EMBC appears in 6 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, EMBC or A?

Our quantitative analysis compares EMBC and A across nine fundamental dimensions. A wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are EMBC and A correlated?

Correlation data is not yet available for this pair. Check back after both stocks have sufficient trading history.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.